What does the evidence say about Reishi Fatigue Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Reishi Fatigue Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Background Chronic fatigue syndrome, or myalgic encephalomyelitis, is characterized by persistent, unexplained exhaustion unalleviated by rest, with a pathophysiology distinct from underlying medical conditions. [Xun Y (2026); evidence level 2] - It is diagnostically complex due to symptoms that overlap with other disorders and the absence of definitive biomarkers, contributing to limited therapeutic options in current medicine. [Xun Y (2026); evidence level 2] - It also critically evaluates the current level of evidence and highlights key limitations related to standardization, variability of extracts, and clinical applicability. [Sadowska Anna (2026); evidence level 3] - Notably, a fungus calledwas found among the belongings of the world’s oldest human mummy, estimated to be about 4000 years old. [Sadowska Anna (2026); evidence level 3] - Ganoderma lucidum In Chinese culture, lingzhi () was celebrated as a superior tonic and a symbol of spiritual power and immortality, and was regarded as the “herb of spiritual potency,” associated with success, well-being, divine power, and long life. [Sadowska Anna (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.